sglt2 vs glp 1 Complementary Yet Distinct Roles of GLP-1 Receptor Agonists and Inhibitors in Cardiovascular Risk Reduction GLP-1 receptor agonists vs. SGLT-2

This guidance recommends that most patients can continue their GLP-1 medications before elective procedures with appropriate risk mitigation strategies, including a 24-hour liquid-only diet before the procedure

Now add GLP-1 medications to the picture

Nearly 46% of patients prefer newer treatment options, while healthcare expansion supports broader accessibility across emerging economies

However, NICE guideline NG28 specifies continuation criteria: treatment should be reviewed after approximately 6 months and only continued if you've achieved both a reduction in HbA1c of at least 11 mmol/mol (1%) and weight loss of at least 3%

An J, Zhou Y, Zhang M, et al

For Tresiba users Monitor fasting blood glucose regularly